Lyric Pharmaceuticals Company
Lyric is a clinical stage company developing novel gastrointestinal therapeutics for unmet medical needs in the hospital setting.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
San Francisco, California, United States
Founded Date:
2013
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
4
Total Funding:
$20.4M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Register and Claim Ownership